Cefdinir Dosage Calculator

Calculate cefdinir (Omnicef) dosage for pediatric and adult patients by weight, indication, and renal function with suspension volume conversion.

⚠️ Medical Disclaimer: This calculator is for educational reference only. Always consult a healthcare provider before prescribing or adjusting medication dosages. Do not rely on this tool for clinical decisions.

Patient Information

kg
years
mL/min
Planning notes, formulas, and examples

About the Cefdinir Dosage Calculator

Cefdinir (brand name Omnicef) is a third-generation oral cephalosporin antibiotic widely prescribed for common bacterial infections in children and adults. It is FDA-approved for acute otitis media, acute maxillary sinusitis, pharyngitis/tonsillitis, community-acquired pneumonia, and uncomplicated skin infections. Pediatric dosing is weight-based at 7 mg/kg twice daily (BID) or 14 mg/kg once daily (QD), with a maximum of 600 mg/day. Adults receive a fixed dose of 300 mg BID or 600 mg QD.

This cefdinir dosage calculator simplifies the process of determining the correct dose based on patient weight, age, chosen indication, and formulation concentration. It automatically converts milligram doses to suspension volumes for the common 125 mg/5 mL and 250 mg/5 mL oral suspensions, estimates the number of bottles needed for the full treatment course, and applies renal dose adjustments when creatinine clearance falls below 30 mL/min.

Accurate antibiotic dosing is critical for therapeutic success and minimizing resistance. Under-dosing cefdinir can lead to treatment failure and promote resistant bacterial strains, while over-dosing increases the risk of gastrointestinal side effects like diarrhea — a known issue with cefdinir, especially in young children. Our calculator includes preset weight ranges for common pediatric ages, indication-specific treatment durations, and a comprehensive reference table for quick bedside verification.

When This Page Helps

Calculating cefdinir doses by hand is error-prone, especially when converting between mg/kg doses and suspension volumes at different concentrations. Our calculator quickly handles the weight-based math, applies renal adjustments, selects the correct treatment duration per indication, and estimates the number of suspension bottles needed for the full course — saving time and reducing dosing errors at the prescribing and dispensing stages.

How to Use the Inputs

  1. Select a preset weight or enter the patient's body weight manually in kg or lb.
  2. Enter the patient's age — this helps distinguish pediatric from adult dosing cutoffs.
  3. Choose the clinical indication from the dropdown to set the recommended treatment duration.
  4. Select the cefdinir formulation (suspension strength or capsule) the pharmacy will dispense.
  5. Pick the dosing frequency: twice daily (BID) or once daily (QD) based on clinician preference.
  6. If the patient has renal impairment, enter the creatinine clearance to apply dose adjustments.
  7. Review the calculated dose, volume per dose, course duration, and reference table for verification.
Formula used
Pediatric dose: mg per dose = weight (kg) × 7 mg/kg (BID) or weight (kg) × 14 mg/kg (QD). Maximum daily dose = 600 mg. Adult dose: 300 mg BID or 600 mg QD. Renal adjustment: if CrCl < 30 mL/min, reduce dose by 50%. Suspension volume (mL) = (dose in mg ÷ concentration in mg) × 5 mL.

Example Calculation

Result: 105 mg (4.2 mL) twice daily for 5 days

A 15 kg child: 15 × 7 = 105 mg per dose BID. Using 125 mg/5 mL suspension: (105 ÷ 125) × 5 = 4.2 mL per dose. For acute otitis media, the standard course is 5 days, totaling 1,050 mg over the full treatment.

Tips & Best Practices

  • Always verify the patient's actual weight — never estimate weight for antibiotic dosing in children.
  • Space cefdinir and iron-containing products (formula, supplements, antacids) at least 2 hours apart.
  • For otitis media in children ≥2 years with mild symptoms, a 5-day course is FDA-approved and often sufficient.
  • Shake the oral suspension well before each dose and use a calibrated oral syringe for accuracy.
  • Counsel parents about the possibility of red-tinged stools from iron interaction — it is benign.
  • Consider once-daily dosing to improve adherence in school-age children.

Cefdinir Pharmacology Overview

Cefdinir belongs to the third-generation cephalosporin class and provides broad-spectrum activity against gram-positive organisms like Streptococcus pneumoniae and Streptococcus pyogenes, as well as gram-negative pathogens including Haemophilus influenzae and Moraxella catarrhalis. Its oral bioavailability is approximately 16–25%, with peak plasma concentrations reached 2–4 hours after dosing. The elimination half-life is about 1.7 hours, but its bacterial killing persists longer due to the time-dependent nature of cephalosporin activity.

Clinical Indications and Evidence

The FDA-approved indications for cefdinir include acute bacterial otitis media (5 days or 10 days), acute maxillary sinusitis (10 days), pharyngitis/tonsillitis (5–10 days), community-acquired pneumonia (10 days), and uncomplicated skin and skin-structure infections (10 days). Multiple randomized controlled trials have demonstrated non-inferiority of cefdinir to amoxicillin-clavulanate for otitis media and to penicillin V for pharyngitis. The once-daily regimen has shown equivalent clinical cure rates to twice-daily dosing in pediatric otitis media studies.

Special Populations and Considerations

In patients with significant renal impairment (CrCl < 30 mL/min), cefdinir clearance is reduced and the dose should be halved. Hemodialysis removes approximately 63% of cefdinir, so supplemental dosing after dialysis sessions is recommended. Cefdinir has not been studied extensively in neonates and is not typically used in infants under 6 months of age. During pregnancy, cefdinir is classified as Category B — animal studies show no fetal harm, but there are no adequate human studies. It is excreted in breast milk in small amounts.

Sources & Methodology

Last updated:

Methodology

This worksheet converts labeled pediatric cefdinir mg/kg/day ranges into per-dose volumes and course totals.

Sources

  • FDA cefdinir labeling (FDA)
  • MedlinePlus: Cefdinir (NIH)
  • Harriet Lane Handbook pediatric dosing references (Elsevier)

Frequently Asked Questions

  • The standard pediatric dose is 7 mg/kg given twice daily or 14 mg/kg given once daily, up to a maximum of 600 mg per day. Both regimens have similar efficacy for most indications.